Clinical and prognostic value of MLN51 (Metastatic lymph node gene 51)/CASC3 (Cancer susceptibility candidate gene 3) in clinical breast cancer, connection with nodal and hormonal receptor status

被引：0
|
作者：
Cong, Binbin
Martin, Tracey
Cao, Xiaoshan
Mansel, Robert E.
Davies, Eleri
Jiang, Wen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-04-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-04-10
引用
收藏
页数：2
相关论文
共 32 条
  • [1] A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles
    Dingfeng Jiang
    Naiqing Zhao
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 579 - 587
  • [2] A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles
    Jiang, Dingfeng
    Zhao, Naiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (09) : 579 - 587
  • [3] Tumor size and lymph node status in breast cancer: can gene expression patterns delineate between clinical phenotypes?
    Danko, M.
    Untch, B. R.
    Acharya, C. R.
    Potti, A.
    Olson, J. A., Jr.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 59 - 59
  • [4] Limited Clinical Utility of Prognostic Gene Expression Profiles in Grade 3 Node-Negative Early Stage Breast Cancer.
    Bedard, P. L.
    Ignatiadis, M.
    Haibe-Kains, B.
    Loi, S.
    Criscitiello, C.
    Desmedt, C.
    Bontempi, G.
    Piccart, M. J.
    Sotiriou, C.
    CANCER RESEARCH, 2009, 69 (24) : 507S - 507S
  • [5] The clinical utility of gene expression assays in breast cancer patients with 0-3 involved lymph nodes
    Barbi, Mali
    Makower, Della
    Sparano, Joseph A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [6] Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1–3 lymph node metastases
    Tomohiro Nogami
    Tadahiko Shien
    Takehiro Tanaka
    Keiko Nishiyama
    Taeko Mizoo
    Takayuki Iwamto
    Hirokuni Ikeda
    Naruto Taira
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Breast Cancer, 2014, 21 : 58 - 65
  • [7] Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases
    Nogami, Tomohiro
    Shien, Tadahiko
    Tanaka, Takehiro
    Nishiyama, Keiko
    Mizoo, Taeko
    Iwamto, Takayuki
    Ikeda, Hirokuni
    Taira, Naruto
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    BREAST CANCER, 2014, 21 (01) : 58 - 65
  • [8] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [9] The Prognostic Value of 18F-FDG Uptake in the Supraclavicular Lymph Node (N3c) on PET/CT in Patients With Locally Advanced Breast Cancer With Clinical N3c
    Lee, Suk Hyun
    Kim, Sung Hoon
    Park, Hyung Seok
    Kim, Joo Heung
    Kim, Dongwoo
    Cho, Hojin
    Yun, Mijin
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E6 - E12
  • [10] The prognostic value of F-18 FDG uptake in the supraclavicular lymph node (N3c) on PET/CT in locally advanced breast cancer patients with clinical N3c
    Lee, S.
    Kim, S.
    Park, H.
    Kim, J.
    Cho, H.
    Yun, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S459 - S459
1234